Motco Has $5.03 Million Stock Position in CME Group Inc. $CME

Motco lowered its stake in CME Group Inc. (NASDAQ:CME) by 3.9% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,071 shares of the financial services provider’s stock after selling 740 shares during the period. Motco’s holdings in CME Group were worth $5,029,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of CME. GQG Partners LLC raised its stake in shares of CME Group by 7,676.3% during the first quarter. GQG Partners LLC now owns 2,205,041 shares of the financial services provider’s stock valued at $584,975,000 after acquiring an additional 2,176,685 shares during the last quarter. Wellington Management Group LLP raised its stake in shares of CME Group by 370.5% during the first quarter. Wellington Management Group LLP now owns 2,653,957 shares of the financial services provider’s stock valued at $704,068,000 after acquiring an additional 2,089,935 shares during the last quarter. Nuveen LLC bought a new position in shares of CME Group during the first quarter valued at $218,842,000. Alliancebernstein L.P. raised its stake in shares of CME Group by 185.5% during the first quarter. Alliancebernstein L.P. now owns 1,244,608 shares of the financial services provider’s stock valued at $330,182,000 after acquiring an additional 808,740 shares during the last quarter. Finally, Egerton Capital UK LLP raised its stake in shares of CME Group by 79.4% during the first quarter. Egerton Capital UK LLP now owns 1,730,194 shares of the financial services provider’s stock valued at $459,003,000 after acquiring an additional 765,773 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Price Performance

Shares of NASDAQ CME opened at $266.33 on Wednesday. CME Group Inc. has a twelve month low of $213.94 and a twelve month high of $290.79. The firm has a fifty day simple moving average of $266.38 and a 200 day simple moving average of $272.08. The company has a market capitalization of $95.98 billion, a PE ratio of 25.81, a P/E/G ratio of 4.58 and a beta of 0.41. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 EPS for the quarter, topping analysts’ consensus estimates of $2.63 by $0.05. The business had revenue of $1.54 billion during the quarter, compared to analysts’ expectations of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The business’s quarterly revenue was down 3.0% on a year-over-year basis. During the same period last year, the company posted $2.68 earnings per share. On average, sell-side analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were issued a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date was Tuesday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 48.45%.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on CME shares. Piper Sandler raised their price target on shares of CME Group from $283.00 to $296.00 and gave the company an “overweight” rating in a research note on Tuesday, July 15th. Wall Street Zen downgraded shares of CME Group from a “hold” rating to a “sell” rating in a research note on Sunday, July 13th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of CME Group in a research note on Wednesday, October 8th. Morgan Stanley lifted their target price on shares of CME Group from $312.00 to $314.00 and gave the stock an “overweight” rating in a research note on Thursday, October 23rd. Finally, UBS Group lowered their target price on shares of CME Group from $285.00 to $280.00 and set a “neutral” rating for the company in a research note on Thursday, October 23rd. Eight investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $284.53.

Insider Activity at CME Group

In other CME Group news, insider Sunil Cutinho sold 11,896 shares of the firm’s stock in a transaction on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total value of $3,229,407.12. Following the completion of the sale, the insider directly owned 17,440 shares in the company, valued at approximately $4,734,436.80. This trade represents a 40.55% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, General Counsel Jonathan L. Marcus sold 392 shares of the firm’s stock in a transaction on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total transaction of $102,704.00. Following the completion of the sale, the general counsel owned 7,851 shares of the company’s stock, valued at $2,056,962. The trade was a 4.76% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 13,043 shares of company stock valued at $3,527,956. Company insiders own 0.30% of the company’s stock.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.